Search research articles
Contact Us
Filters
Showing results (181-190 of 206) with videos related to
Page
of 21
Sort By:
The American Journal of Cardiology
|
September 1, 1993
Open, noncontrolled dose-finding study with a novel recombinant plasminogen activator (BM 06.022) given as a double bolus in patients with acute myocardial infarction
U Tebbe, R von Essen, A Smolarz, et al.
The Thoracic and Cardiovascular Surgeon
|
April 1, 1990
Transfemoral placement of the left ventricular assist device "Hemopump" during mechanical resuscitation
K H Scholz, U Tebbe, M Chemnitius, et al.
Journal of the American College of Cardiology
|
September 1, 1988
Intravenous recombinant tissue plasminogen activator (rt-PA) and urokinase in acute myocardial infarction: results of the German Activator Urokinase Study (GAUS)
K L Neuhaus, U Tebbe, M Gottwik, et al.
Klinische Wochenschrift
|
January 1, 1988
[Intravenous infusion of recombinant tissue-type plasminogen activator (rt-PA) and urokinase in acute myocardial infarct: intermediate results of the G.A.U.S. study (German Activator Urokinase Study)]
K L Neuhaus, U Tebbe, M Gottwik, et al.
Deutsche Medizinische Wochenschrift (1946)
|
July 14, 2007
[Reduction of in-hospital mortality and improved secondary prevention after acute myocardial infarction. First results from the registry of secondary prevention after acute myocardial infarction (SAMI)]
U Tebbe, C Messer, E Stammwitz, et al.
Zeitschrift Fur Kardiologie
|
September 15, 2004
Antibody levels against Chlamydia pneumoniae and outcome of roxithromycin therapy in patients with acute myocardial infarction. Results from a sub-study of the randomised Antibiotic Therapy in Acute Myocardial Infarction (ANTIBIO) trial
U Burkhardt, R Zahn, U Höffler, et al.
Journal of the American College of Cardiology
|
July 1, 1994
Dose finding with a novel recombinant plasminogen activator (BM 06.022) in patients with acute myocardial infarction: results of the German Recombinant Plasminogen Activator Study. A study of the Arbeitsgemeinschaft Leitender Kardiologischer Krankenhausärzte (ALKK)
K L Neuhaus, R von Essen, A Vogt, et al.
Journal of the American College of Cardiology
|
November 13, 2001
The Na(+)/H(+) exchange inhibitor eniporide as an adjunct to early reperfusion therapy for acute myocardial infarction. Results of the evaluation of the safety and cardioprotective effects of eniporide in acute myocardial infarction (ESCAMI) trial
U Zeymer, H Suryapranata, J P Monassier, et al.
Deutsche Medizinische Wochenschrift (1946)
|
October 27, 1999
[30-day mortality after heart surgery: a pilot project of the Working Party of Directors of Hospital Cardiology Departments]
M Gottwik, R Kretschmar, A Vogt, et al.
Annales De Cardiologie Et D'Angeiologie
|
August 5, 2004
[Cypher stent: the German registry. Results of the German prospective multicenter registry on Cypher]
R Zahn, C W Hamm, U Zeymer, et al.
Page
of 21
Search research articles
Search
Showing results (181-190 of 206) with videos related to
Sort By:
Page
of 21
The American Journal of Cardiology
|
September 1, 1993
Open, noncontrolled dose-finding study with a novel recombinant plasminogen activator (BM 06.022) given as a double bolus in patients with acute myocardial infarction
U Tebbe, R von Essen, A Smolarz, et al.
The Thoracic and Cardiovascular Surgeon
|
April 1, 1990
Transfemoral placement of the left ventricular assist device "Hemopump" during mechanical resuscitation
K H Scholz, U Tebbe, M Chemnitius, et al.
Journal of the American College of Cardiology
|
September 1, 1988
Intravenous recombinant tissue plasminogen activator (rt-PA) and urokinase in acute myocardial infarction: results of the German Activator Urokinase Study (GAUS)
K L Neuhaus, U Tebbe, M Gottwik, et al.
Klinische Wochenschrift
|
January 1, 1988
[Intravenous infusion of recombinant tissue-type plasminogen activator (rt-PA) and urokinase in acute myocardial infarct: intermediate results of the G.A.U.S. study (German Activator Urokinase Study)]
K L Neuhaus, U Tebbe, M Gottwik, et al.
Deutsche Medizinische Wochenschrift (1946)
|
July 14, 2007
[Reduction of in-hospital mortality and improved secondary prevention after acute myocardial infarction. First results from the registry of secondary prevention after acute myocardial infarction (SAMI)]
U Tebbe, C Messer, E Stammwitz, et al.
Zeitschrift Fur Kardiologie
|
September 15, 2004
Antibody levels against Chlamydia pneumoniae and outcome of roxithromycin therapy in patients with acute myocardial infarction. Results from a sub-study of the randomised Antibiotic Therapy in Acute Myocardial Infarction (ANTIBIO) trial
U Burkhardt, R Zahn, U Höffler, et al.
Journal of the American College of Cardiology
|
July 1, 1994
Dose finding with a novel recombinant plasminogen activator (BM 06.022) in patients with acute myocardial infarction: results of the German Recombinant Plasminogen Activator Study. A study of the Arbeitsgemeinschaft Leitender Kardiologischer Krankenhausärzte (ALKK)
K L Neuhaus, R von Essen, A Vogt, et al.
Journal of the American College of Cardiology
|
November 13, 2001
The Na(+)/H(+) exchange inhibitor eniporide as an adjunct to early reperfusion therapy for acute myocardial infarction. Results of the evaluation of the safety and cardioprotective effects of eniporide in acute myocardial infarction (ESCAMI) trial
U Zeymer, H Suryapranata, J P Monassier, et al.
Deutsche Medizinische Wochenschrift (1946)
|
October 27, 1999
[30-day mortality after heart surgery: a pilot project of the Working Party of Directors of Hospital Cardiology Departments]
M Gottwik, R Kretschmar, A Vogt, et al.
Annales De Cardiologie Et D'Angeiologie
|
August 5, 2004
[Cypher stent: the German registry. Results of the German prospective multicenter registry on Cypher]
R Zahn, C W Hamm, U Zeymer, et al.
Page
of 21